Related Experiment Video
Updated: May 28, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Colistin pharmacokinetics: the fog is lifting
W Couet1, N Grégoire, S Marchand
1Inserm ERI-23, CHU, Service de Toxicologie et Pharmacocinétique, UFR Médecine-Pharmacie, Université de Poitiers, Poitiers, France. william.couet@univ-poitiers.fr
Abstract:
Colistin is a re-emerging old antibiotic that is used to treat multidrug-resistant infections in critically ill patients. It corresponds to a mixture of at least 30 different compounds administered as inactive derivatives. Therefore, colistin pharmacokinetics are quite difficult to investigate and complex to predict. However specific chromatographic methods have been made available in recent years, leading to a series of modern pharmacokinetic studies after intravenous administration of the prodrug to critical-care patients; these have been conducted by a few groups and have only been recently published. The objective of this article was to conduct a critical review of these very informative modern pharmacokinetic studies and to provide prospective thoughts.
More Related Videos
Related Concept Videos
Pharmacokinetics: Overview
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Clearance Models: Compartment Models
Pharmacodynamic Models: Overview
Clinical Significance of Antibiotic Resistance

